From: Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
Characteristic | Univariate analysis | Multivariable analysis | ||
---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Age | ||||
≤ 55 vs. >55 | 0.612 (0.357–1.049) | 0.074 | 0.770 (0.451–1.315) | 0.338 |
Sex | ||||
Female vs. Male | 0.823 (0.490–1.382) | 0.462 | 0.542 (0.298–0.988) | 0.045* |
Location | ||||
Mucosa vs. Skin | 2.636 (1.223–5.680) | 0.013* | 2.667 (1.090–6.526) | 0.032* |
Acral vs. Skin | 2.064 (0.823–5.173) | 0.122 | 2.113 (0.767–5.824) | 0.148 |
Other vs. Skin | 1.186 (0.395–3.558) | 0.761 | 1.069 (0.321–3.560) | 0.913 |
Neuroendocrinea | 0.854 (0.510–1.432) | 0.550 | 0.865 (0.477–1.569) | 0.633 |
BRAF alternations | 0.797 (0.452–1.406) | 0.434 | 1.071 (0.546–2.101) | 0.842 |